Provided by Tiger Trade Technology Pte. Ltd.

Cocrystal Pharma, Inc.

1.25
+0.01000.81%
Volume:26.20K
Turnover:32.75K
Market Cap:24.08M
PE:-1.64
High:1.27
Open:1.26
Low:1.22
Close:1.24
52wk High:2.67
52wk Low:0.7600
Shares:19.26M
Float Shares:11.85M
Volume Ratio:0.78
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7613
EPS(LYR):-0.7822
ROE:-311.68%
ROA:-96.07%
PB:23.06
PE(LYR):-1.60

Loading ...

Cocrystal Pharma Doses Last Patient in Phase 1b Norovirus Challenge Trial of CDI-988

Reuters
·
Sep 09

Cocrystal Pharma - no Serious Adverse Events Reported to Date in Cdi-988 Phase 1B Study

THOMSON REUTERS
·
Sep 09

Cocrystal Pharma Announces Last Subject Dosed in Phase 1B Human Challenge Study Evaluating Cdi-988 for Norovirus Prevention and Treatment

THOMSON REUTERS
·
Sep 09

Cocrystal Pharma - Preliminary Efficacy Results for Cdi-988 Expected Late 2026 or Early 2027

THOMSON REUTERS
·
Sep 09

Cocrystal Pharma Appoints Carol Brosgart, Md to Its Board of Directors

THOMSON REUTERS
·
Aug 17

Cocrystal Pharma Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Cocrystal Pharma Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $105.000K

Benzinga Earnings
·
Aug 13

Cocrystal Pharma Q2 FY26 Net Loss Widens to $3.16 Million; R&D Expense Climbs to $2.14 Million

Reuters
·
Aug 13

Cocrystal Pharma Inc Expected to Post a Loss of 16 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Cocrystal Pharma Director Phillip Frost Reports $9,816 Common Share Purchase

Reuters
·
Aug 07

Cocrystal Pharma Sells 5,474,053 Shares to OPKO in USD 5 Million Private Placement

Reuters
·
Aug 03

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

THOMSON REUTERS
·
Aug 03

Cocrystal Pharma Holds Annual Shareholder Meeting

Reuters
·
Jul 17

Cocrystal Pharma files Form 3 for CEO James Sapirstein```

Reuters
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

Cocrystal Pharma names James Sapirstein CEO, replacing co-CEOs Lee and Martin

Reuters
·
Jun 03

Cocrystal Pharma - SAM Lee to Transition to Chief Scientific Officer; Jim Martin to Continue as CFO

THOMSON REUTERS
·
Jun 03

Cocrystal Pharma - Plans to Appoint James Sapirstein to Board of Directors

THOMSON REUTERS
·
Jun 03

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader With Extensive Antiviral Development Experience, as Chief Executive Officer

THOMSON REUTERS
·
Jun 03